Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Johnson and Johnson
Chubb
Covington
Citi
Deloitte
Farmers Insurance
Colorcon

Generated: May 27, 2018

DrugPatentWatch Database Preview

ORA-TESTRYL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ora-testryl, and when can generic versions of Ora-testryl launch?

Ora-testryl is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in ORA-TESTRYL is fluoxymesterone. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluoxymesterone profile page.
Summary for ORA-TESTRYL
Drug patent expirations by year for ORA-TESTRYL
Medical Subject Heading (MeSH) Categories for ORA-TESTRYL
Synonyms for ORA-TESTRYL
(11beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
(1R,2S,10S,11S,14S,15S,17S)-1-fluoro-14,17-dihydroxy-2,14,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one
(1R,2S,10S,11S,14S,15S,17S)-1-FLUORO-14,17-DIHYDROXY-2,14,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE
(8S,9R,10S,11S,13S,14S,17S)-9-fluoranyl-10,13,17-trimethyl-11,17-bis(oxidanyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
010F480
11-beta,17-beta-Dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one
11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one
11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one
17-alpha-Methyl-9-alpha-fluoro-11-beta-hydroxytesterone
17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone
4-08-00-02057 (Beilstein Handbook Reference)
76-43-7
9-alpha-Fluoro-11-beta-hydroxy-17-methyltestosterone
9-alpha-Fluoro-11-beta,17-beta-dihydroxy-17-alpha-methyl-4-androstene-3-one
9-alpha-Fluoro-17-alpha-methyl-11-beta,17-dihydroxy-4-androsten-3-one
9-Fluoro-11-beta,17-beta-dihydroxy-17-methylandrost-4-en-3-one
9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one
9-fluoro-11beta,17beta-dihydroxy-17alpha-methylandrost-4-en-3-one
9.alpha.-Fluoro-11.beta.-hydroxy-17-methyltestosterone
9.alpha.-Fluoro-11.beta.,17.beta.-dihydroxy-17.alpha.-methyl-4-androstene-3-one
92481-EP2295416A2
92481-EP2295426A1
92481-EP2295427A1
92481-EP2298748A2
92481-EP2305642A2
9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone
9alpha-Fluoro-11beta-hydroxy-17alpha-methyltestosterone
9alpha-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one
9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methyl-4-androstene-3-one
9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methylandrost-4-en-3-one
9alpha-Fluoro-17alpha-methyl-11beta,17-dihydroxy-4-androsten-3-one
9JU12S4YFY
A838701
AC1L1MJU
AI3-52940
AKOS015895109
AN-23896
Anadroid-F
Androfluorene
Androfluorone
Android-f
Androst-4-en-3-one, 9-fluoro-11-beta,17-beta-dihydroxy-17-methyl-
Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11beta,17beta)-
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl-
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl- (VAN)
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl- (VAN) (8CI)
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl-(VAN)
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl-(VAN) (8CI)
Androsterolo
Androxy
BDBM18189
BRN 2008796
C-20222
CAS-76-43-7
CC-28509
CCRIS 9036
CHEBI:5120
CHEMBL1445
component of Halodrin
D00327
D0L2LS
DB01185
DSSTox_CID_13512
DSSTox_GSID_33512
DSSTox_RID_79080
DTXSID8033512
EINECS 200-961-8
Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3
Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3 [French]
Fluossimesterone
Fluossimesterone [DCIT]
Fluosterone
Fluotestin
Fluoximesteron
Fluoximesterona
Fluoximesterona [INN-Spanish]
Fluoximesterone
Fluoximesteronum
Fluoxymesteron
fluoxymesterone
Fluoxymesterone (JP15/USP/INN)
Fluoxymesterone (JP17/USP/INN)
Fluoxymesterone [INN:BAN:JAN]
Fluoxymesterone [USP:INN:BAN:JAN]
Fluoxymesterone 1.0 mg/ml in Acetonitrile
Fluoxymesterone, solid (photosensitive)
Fluoxymesteronum
Fluoxymesteronum [INN-Latin]
Fluoxymestrone
Flusteron
Flutestos
FXM
GTPL2861
Halotestin
Halotestin (TN)
HMS2272B06
HSDB 3333
LMST02020025
LS-19496
MLS001055414
NCGC00091037-01
NCGC00091037-02
NCGC00182970-01
NCGC00258408-01
Neo-Ormonal
NSC 10704
NSC-10704
NSC-12165
NSC10704
NSC12165
Ora Testryl
Oralsterone
Oratestin
PL000264
PubChem5785
SCHEMBL5096
SMR000686158
Testoral
Testosterone, 9-fluoro-11.beta.-hydroxy-17-methyl-
Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-
Tox21_113158
Tox21_200854
U 6040
Ultandren
Ultandrene
UNII-9JU12S4YFY
W-104363
ZINC3875484

US Patents and Regulatory Information for ORA-TESTRYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb ORA-TESTRYL fluoxymesterone TABLET;ORAL 011359-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ORA-TESTRYL fluoxymesterone TABLET;ORAL 011359-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Federal Trade Commission
Express Scripts
Baxter
UBS
Mallinckrodt
Dow
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.